ESC Premium Access

Individual-specific corrected QT interval (QTcI) obtained from ECGs recorded at fixed timepoints versus QTcI derived using a wider range of stable heart rates from 24-hour Holter recordings

Congress Presentation

About the speaker

Doctor Rick Turner

QuintilesIMS, Durham (United States of America)
0 follower

4 more presentations in this session

Discussant: Best Posters in new targets in cardiovascular drug assessment


Initial clinical experience with AZD5718, a novel once daily oral 5-lipoxygenase activating protein (FLAP) inhibitor, intended for patients with coronary artery disease

Speaker: Associate Professor S. Skrtic (Molndal, SE)


Lack of low-density lipoprotein cholesterol (LDL-C) goal attainment among high-risk patients using high or moderate intensity statin therapy in Germany

Speaker: Doctor M. Hatz (Munich, DE)


Role of ivabradine in development of new onset atrial fibrillation in acute coronary syndrome patients

Speaker: Doctor A. Almaghraby (Alexandria, EG)


Access the full session

Best Posters 3 - Best Posters in new targets in cardiovascular drug assessment

Speakers: Doctor R. Turner, Associate Professor S. Skrtic, Doctor M. Hatz, Doctor A. Almaghraby

About the event



26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk